AU2003223619A1 - Antiviral phosphorothioate oligonucleotides - Google Patents

Antiviral phosphorothioate oligonucleotides

Info

Publication number
AU2003223619A1
AU2003223619A1 AU2003223619A AU2003223619A AU2003223619A1 AU 2003223619 A1 AU2003223619 A1 AU 2003223619A1 AU 2003223619 A AU2003223619 A AU 2003223619A AU 2003223619 A AU2003223619 A AU 2003223619A AU 2003223619 A1 AU2003223619 A1 AU 2003223619A1
Authority
AU
Australia
Prior art keywords
antiviral
phosphorothioate oligonucleotides
phosphorothioate
oligonucleotides
antiviral phosphorothioate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003223619A
Inventor
Zhidong Chen
Richard Koehn
Dinesh Patel
Duane Ruffner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salus Therapeutics Inc
Original Assignee
Salus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salus Therapeutics Inc filed Critical Salus Therapeutics Inc
Publication of AU2003223619A1 publication Critical patent/AU2003223619A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003223619A 2002-05-13 2003-04-16 Antiviral phosphorothioate oligonucleotides Abandoned AU2003223619A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14436002A 2002-05-13 2002-05-13
US10/144,360 2002-05-13
PCT/US2003/011593 WO2003097661A2 (en) 2002-05-13 2003-04-16 Antiviral phosphorothioate oligonucleotides

Publications (1)

Publication Number Publication Date
AU2003223619A1 true AU2003223619A1 (en) 2003-12-02

Family

ID=29548252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003223619A Abandoned AU2003223619A1 (en) 2002-05-13 2003-04-16 Antiviral phosphorothioate oligonucleotides

Country Status (2)

Country Link
AU (1) AU2003223619A1 (en)
WO (1) WO2003097661A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008940B1 (en) 2002-09-13 2007-10-26 Репликор, Инк. Non-sequence complementary antiviral oligonucleotides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products

Also Published As

Publication number Publication date
WO2003097661A2 (en) 2003-11-27
WO2003097661A3 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2003237249A1 (en) Oligonucleotides having modified nucleoside units
AU2003241621A1 (en) Oligonucleotides having modified nucleoside units
AU2003295539A1 (en) Allele-targeted rna interference
AU2003290597A1 (en) Modified oligonucleotides for use in rna interference
EP1575980A4 (en) Rna interference
AU2002351077A1 (en) Oligonucleotides modified with novel alpha-l-rna analogues
WO2003018621A8 (en) Genes
AU2002358463A1 (en) Oligonucleotide analogues comprising intercalator pseudonucleotides
GB0219143D0 (en) Modified tailed oligonucleotides
AU2003268055A1 (en) Distributed computations
AU2002350631A1 (en) Phosphorothioate-modified oligonucleotide as anti-restenosis agent
AU2003278857A1 (en) Oligonucleotide conjugates
AU2002257446A1 (en) Antiviral nucleosides
AU2003242678A1 (en) Antisense oligonucleotides against pim1
AU2003281867A1 (en) Antisense nucleic acids
AU2003223619A1 (en) Antiviral phosphorothioate oligonucleotides
AU2003294705A8 (en) Ntsm gene
IL157805A0 (en) Immobilized oligonucleotides
AU2003286495A1 (en) Rna-based inhibitory oligonucleotides
AU2003277902A8 (en) Acc gene
ZA200502005B (en) Non-sequence complementary antiviral oligonucleotides
AU2003238501A1 (en) Hybridization chamber
AUPR282501A0 (en) Expression facilitating nucleotides
AU2003241762A1 (en) Dna shuflling
AU2003232476A1 (en) Antiviral lactone-ureas

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase